We further confirmed the ability of MPOCs to deliver the
PNAs in another cell line. Comparing to the commercially
available reagent, FuGENE-HD (positively charged liposome),
using flow cytometry, MPOCs showed significantly higher
efficiency in delivering PNAs into the 293T human embryonic
kidney (HEK293T) cells (Supporting Information, Figure S8).